Seres Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2017
Total Assets: $189.5M
Liabilities Breakdown FY2017
Total Liabilities: $128.8M
Asset Breakdown
Total Assets: $189.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $36.1M | 19.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $32.9M | 17.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $120.5M | 63.6% |
Liabilities Breakdown
Total Liabilities: $128.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.0M | 5.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $121.8M | 94.5% |